Caribou Biosciences

• Lead clinical study in execution, including planning, conduct, data review, and reporting for Phase I and II trials in hematologic malignancies • Own ongoing clinical data review, ensuring patient safety and data integrity; identify trends and drive data informed decisions • Lead safety monitoring activities including review of adverse events and CAR-T associated toxicities (ie: CRS, ICANS) and contribute to dose escalation decisions • Drive cross-functional collaboration with Clinical Operations, Translational Sciences, Data Management, Biostatistics, Regulatory, and CMC teams to ensure high-quality study execution • Lead authorship of key study documents, including protocols, Investigator’s Brochures, clinical study reports, regulatory documents, and safety narratives • Integrate clinical and translational data (ie: cell expansion, persistence, biomarker data) to generate insights and inform program strategy • Contribute to regulatory strategy and submissions, including IND-related documents and health authority responses • Serve as a scientific lead at the study level, engaging with investigators, CROs, and key opinion leaders • Support development of publications, abstracts, and presentations for scientific conferences • Ensure compliance with GCP, internal SOPs, and regulatory requirements